Compass Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Pipeline Progress ESAB Q1 2026 Earnings EPS Slightly Misses Expectations Amid Steady Execution PB Q1 2026 Earnings EPS Misses Estimates Amid Challenging Rate Environment REG Q1 2026 Earnings Strong EPS Beat Signals Operational Resilience AMTD IDEA Group Q4 2020 Earnings Strong EPS Beat Amid Revenue Disclosure Gap MAT Q1 2026 Earnings NarrowerthanExpected Loss Drives Modest Stock Uptick